Latest News
Latest News
The Rising Tide of Atrial Fibrillation: Is Primary Care Ready?
Lifestyle choices such as sleeping habits can contribute to AF outcomes.
Commentary
A Doctor Gets the Save When a Little League Umpire Collapses
Surgical oncologist aids umpire hit by a ball during a Little League game.
From the Journals
Can Restricting Carbohydrates Cut the Need for Medication in T2D?
“Our results are the first to show that dietary carbohydrate restriction can improve beta-cell function,” said study author Marian L. Yurchishin...
From the Journals
Diabetes Retinopathy Poses Threat to More Young People’s Sight
The current standards of care for retinopathy from the ADA note new products on the market are increasing the options for screening.
Commentary
Is CGM the New CBT?
Continuous glucose monitoring can help patients through a “carrot and stick” approach to dieting.
Feature
Therapeutic Drug Monitoring in Rheumatology: A Promising Outlook But Many Barriers to Overcome
Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome before it’s widely...
From the Journals
Few Differences Seen in RA Pain Outcomes for JAK Inhibitors, Biologics
JAK inhibitors were found to be either marginally more effective or as effective as biologic DMARDs in reducing pain in patients with rheumatoid...
Latest News
How Much Does Long COVID Cost Society? New Data Shed Light
Long COVID is estimated to affect 6%-7% of adults; those afflicted are often unable to work for extended periods, and some simply stop working...
Latest News
Groups With Highest Unmet Need for PrEP Highlighted in Analysis
Men living in predominantly Black or Hispanic neighborhoods, or who are insured by Medicaid, saw lower proportions of PrEP use despite higher...
News
FDA OKs Novel Levodopa-Based Continuous Sub-Q Regimen for Parkinson’s Disease
This new, non-surgical regimen provides continuous delivery of levodopa morning, day, and night.
From the Journals
Adjuvant Chemo Beneficial in TNBC With High Immune Infiltration
Researchers conducted a retrospective analysis of a phase 3 trial to identify the specific population that benefited from adjuvant capecitabine....